Montauk Renewables, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023; filed March 14, 2024. This is an annual report, not a standalone fourth-quarter report, and the filing text does not provide clear standalone Q4 financial results. Dollar amounts below are in millions unless stated otherwise.
Business context
Montauk develops, owns and operates renewable natural gas (RNG) and renewable electricity projects that recover biogas, primarily from landfills and, increasingly, agricultural waste. At year-end, it operated 12 RNG projects and three renewable electricity projects across six states. Environmental attributes—including D3 RINs, LCFS credits and RECs—are a major source of revenue.
Financial and operating performance
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Operating revenue | $174.9 | $205.6 | Down 14.9% |
| Operating income | $23.6 | $44.6 | Down 47.0% |
| Net income | $14.9 | $35.2 | Down 57.5% |
| Diluted EPS | $0.11 | $0.25 | Down $0.14 |
| Adjusted EBITDA (non-GAAP) | $46.5 | $70.5 | Down 34.2% |
| Operating cash flow | $41.1 | $81.1 | Down 49.4% |
| Capital expenditures | $63.1 | $22.3 | Up $40.8 |
Operating margin was approximately 13.5% (21.7% in 2022); net margin was approximately 8.5% (17.1% in 2022). The company attributed the revenue decline mainly to lower realized D3 RIN prices ($2.71 versus $3.25) and lower natural-gas index prices. RNG production was nearly flat at 5.499 million MMBtu, down 0.4%; renewable electricity production rose 2.1% to 194,000 MWh. RNG segment revenue fell 20.3% to $156.5 million, while renewable electricity revenue increased 7.4% to $18.4 million.
Environmental attributes generated 76% of operating revenue in 2023, versus 70% in 2022. Operating expenses declined 6.0% to $151.3 million, helped by lower royalties and lower impairment charges, but operating income was pressured by the revenue decline. Interest expense rose to $5.8 million from $1.8 million amid higher rates. The company recorded $0.9 million of impairment losses, compared with $4.9 million in 2022.
Cash and cash equivalents were $73.8 million at year-end, down from $105.2 million. Investing activities used $63.1 million, primarily for development and facility investment; financing activities used $9.3 million. Long-term debt before debt issuance costs was $64.0 million, down from $72.0 million; the $120 million revolving facility was undrawn, with $117.5 million available after letters of credit. The facility matures in December 2026. The company reported compliance with its financial covenants. Current assets were $90.2 million and current liabilities $29.4 million.
Material changes and developments
- Lower RIN and natural-gas prices drove much of the revenue and earnings decline, while RNG output remained broadly stable.
- Cash from operations nearly halved as cash generation fell and working capital used funds; capital spending increased substantially.
- Rumpke faced weather and wellfield-extraction issues, while McCarty had feedstock quality and volume issues. Dry conditions and higher temperatures also reduced output at some sites.
- The company continued major growth projects: the second Apex RNG facility was targeted for late 2024; Blue Granite and Bowerman RNG projects were then expected in 2026. Pico’s digestion expansion was expected to ramp during 2024.
- Montauk Ag’s North Carolina project remained under development, with first revenue expected in 2025; the company estimated first-phase investment at $140–160 million.
Outlook, risks and unusual items
Management expected 2024 non-development capital expenditures of $14–17 million and development spending of $135–150 million. It said cash from operations and borrowing availability should meet debt service and anticipated capital needs over the next 12–24 months, while noting that operating and business risks could affect liquidity. These are forward-looking estimates, not guarantees.
In February 2024, Montauk agreed to sell gas rights at a renewable-electricity site for $1.0 million, effective October 1, 2024, ahead of the site’s fuel-supply expiration and PPA expiry. It also secured five-year extensions to fuel-supply agreements at two RNG sites. Separately, it signed a long-term agreement to deliver biogenic CO2 from Texas facilities for an e-methanol project, with first delivery expected in 2027 and planned investment of approximately $15 million per facility.
Management chose not to commit significant available RINs to transfer in early 2024. At the filing date, it reported approximately 2.887 million RINs from 2023 production and 7.250 million from 2024 production in inventory, without transfer commitments. The filing reported an average D3 RIN index price of about $3.30 for Q4 2023 and January 2024, and $3.06 through February 2024.
Key risks include dependence on environmental-credit programs and volatile RIN, LCFS and commodity prices; concentration in a small number of projects, customers and regions; extreme weather and site-level feedstock or wellfield problems; reliance on landfill partners, pipelines and utility interconnections; development, commissioning and permitting delays; and higher interest costs. EPA biogas regulatory reforms require industry compliance during 2024 and by January 1, 2025. Proposed California LCFS changes could alter credit supply, values and eligibility. The $64 million variable-rate term loan also faces a reference-rate transition when BSBY ceases in November 2024. Five locations generated about 68% of 2023 operating revenue; Valero, GE Warren and HF Sinclair represented 22.0%, 11.7% and 11.7%, respectively.
No material pending litigation was reported. The auditor gave an unqualified opinion on the financial statements; it did not attest to internal-control effectiveness because Montauk is an emerging growth company. Management concluded disclosure controls and internal control over financial reporting were effective at year-end. Montauk did not pay dividends in 2023.
Important facts for investors to verify
- Whether lower D3 RIN and gas prices persist, and when the uncommitted RIN inventory is sold and recognized as revenue.
- Progress, commissioning dates, total costs and funding for Montauk Ag, Apex, Bowerman, Blue Granite and the CO2 project.
- Whether Rumpke and McCarty feedstock and wellfield issues are resolved, and whether production availability recovers.
- Available liquidity after planned development spending, debt amortization and the 2026 facility maturity; confirm covenant headroom and the BSBY-to-SOFR transition terms.
- Effects of EPA RFS reforms and California LCFS rulemaking on credit eligibility, volumes and prices, especially for agricultural projects.